Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: Some reasons why Journal Article


Author: Cohen, M. A.
Article Title: Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: Some reasons why
Abstract: There are several reasons that explain the false-negative core-needle biopsy rate for atypical lobular hyperplasia or lobular carcinoma in situ (LCIS): Some are technical, as in the failure to adequately target the lesion; some are interpretive, as in the misdiagnosis of low-grade solid ductal carcinoma in situ as LCIS; and some are biological, as would occur if a population of LCIS lesions were truly premalignant.
Keywords: immunohistochemistry; histopathology; review; treatment planning; diagnostic accuracy; evidence based medicine; diagnostic procedure; breast; differential diagnosis; breast neoplasms; uvomorulin; cancer invasion; mammography; diagnostic value; biopsy, needle; breast carcinoma; carcinoma in situ; hyperplasia; needle biopsy; diagnostic error; tamoxifen; radiodiagnosis; breast surgery; technique; carcinoma, intraductal, noninfiltrating; breast biopsy; carcinoma, lobular; breast hyperplasia; precancer; tamoxifen citrate; humans; human; female; priority journal; breast, biopsy; breast, neoplasms, diagnosis; editorials; breast atypical lobular hyperplasia
Journal Title: Radiology
Volume: 231
Issue: 3
ISSN: 0033-8419
Publisher: Radiological Society of North America, Inc.  
Date Published: 2004-06-01
Start Page: 617
End Page: 621
Language: English
DOI: 10.1148/radiol.2313040154
PROVIDER: scopus
PUBMED: 15163803
DOI/URL:
Notes: Radiology -- Cited By (since 1996):40 -- Export Date: 16 June 2014 -- CODEN: RADLA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael A Cohen
    14 Cohen